2Indexed trials
drug · Product Intelligence
Donepezil Hydrochloride
Pipeline Intelligence
Donepezil Hydrochloride: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 13 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
13FDA-linked events
Development evidence
NCT00688376Eisai Inc. · pain_neuropathyPHASE3
NCT02162251Eisai Co., Ltd. · alzheimersCOMPLETED
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALMEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE · 2023-12-15
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2018-07-27
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2016-02-19
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2013-07-24
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2013-07-05
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2013-02-25
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-08-29
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.